source
- Mimetic Medicines' peptide reduces pain-related sodium channels in mice, offering new neuropathic pain strategyResearchers at Mimetic Medicines tested a short lipidated peptide (SLiP) in mice and found it lowered the presence of Nav1.8 sodium channels on sensory neuron membranes. Reducing these channels hel…
- Two Massachusetts biotech firms shut down, ending cancer and eye‑disease programsAdecto Pharmaceuticals, a Boston‑based biotech developing a treatment for cancers resistant to standard immunotherapy, announced it has ceased operations as of September 30. CEO Nora Minerva shared…